19 results
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
of our service providers and, in some cases, wind-down costs. The exact amounts of such obligations are dependent on the timing of termination
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
cases, wind-down costs. The exact amounts of such obligations are dependent on the timing of termination and the terms of the associated agreement
10-Q
w5u49w5x2gs0
28 Aug 23
Quarterly report
8:00am
424B4
d3mpn
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1
EX-10.9
vgich6zd
22 Jun 23
IPO registration
4:19pm
S-1
uc87dlptgs1pgsxa9a
22 Jun 23
IPO registration
4:19pm
S-1
EX-10.7
sf1vjz6v81 aqs
22 Jun 23
IPO registration
4:19pm
S-1
EX-3.1
tkgi55q589qwh
22 Jun 23
IPO registration
4:19pm
S-1
EX-10.10
086s0bdh762
22 Jun 23
IPO registration
4:19pm
DRS/A
EX-10.9
0fjcigcuya233pvz
5 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
k1e cm4yex
5 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
qys8v
5 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-3.1
aaidxjo7c 2aafo
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
EX-3.1
ua220hlancbctdwsd
28 Apr 23
Draft registration statement
12:00am
DRS
ho5erk
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next